The University of Chicago Header Logo

Connection

Walter M. Stadler to Vascular Endothelial Growth Factor Receptor-1

Back to Details
This is a "connection" page, showing publications Walter M. Stadler has written about Vascular Endothelial Growth Factor Receptor-1.
Walter M. Stadler
Connection Strength
0.017
Vascular Endothelial Growth Factor Receptor-1
  1. Phase I dose escalation and pharmacokinetic study of AZD2171, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinase, in patients with hormone refractory prostate cancer (HRPC). Invest New Drugs. 2007 Oct; 25(5):445-51.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.